| Autor: |
de Assis Gadelha, Danilo Duarte, de Brito Alves, José Luiz, Trindade da Costa, Paulo César, Sousa da Luz, Mickael, de Oliveira Cavalcanti, Clênia, França Bezerril, Fabrícia, Franco Almeida, Juliana, de Campos Cruz, Josiane, Magnani, Marciane, Moura Balarini, Camille, Rodrigues Mascarenhas, Sandra, de Andrade Braga, Valdir, do Socorro de França-Falcão, Maria |
| Předmět: |
|
| Zdroj: |
Critical Reviews in Food Science & Nutrition; 2024, Vol. 64 Issue 12, p3839-3860, 22p |
| Abstrakt: |
Hypertension is the leading risk factor for cardiovascular diseases and is associated with intestinal dysbiosis with a decrease in beneficial microbiota. Probiotics can positively modulate the impaired microbiota and impart benefits to the cardiovascular system. Among them, the emended Lactobacillus has stood out as a microorganism capable of reducing blood pressure, being the target of several studies focused on managing hypertension. This review aimed to present the potential of Lactobacillus as an antihypertensive non-pharmacological strategy. We will address preclinical and clinical studies that support this proposal and the mechanisms of action by which these microorganisms reduce blood pressure or prevent its elevation. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
